These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37257480)

  • 1. [Role of Complement in Kidney Diseases - New Aspects].
    Zipfel PF; Zipfel S; Wiech T
    Dtsch Med Wochenschr; 2023 Jun; 148(12):774-779. PubMed ID: 37257480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
    Front Immunol; 2020; 11():599417. PubMed ID: 33362783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
    Zipfel PF; Wiech T; Rudnick R; Afonso S; Person F; Skerka C
    Front Immunol; 2019; 10():2166. PubMed ID: 31611870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and kidney disease.
    Cook HT
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):295-301. PubMed ID: 23508058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated kidney diseases.
    Poppelaars F; Thurman JM
    Mol Immunol; 2020 Dec; 128():175-187. PubMed ID: 33137606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking down the complement system: a review and update on novel therapies.
    Reddy YN; Siedlecki AM; Francis JM
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):123-128. PubMed ID: 27977428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and glomerular diseases.
    Popat RJ; Robson MG
    Nephron Clin Pract; 2014; 128(3-4):238-42. PubMed ID: 25412932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement in glomerular diseases.
    Tan Y; Zhao MH
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the complement cascade: novel treatments coming down the pike.
    Thurman JM; Le Quintrec M
    Kidney Int; 2016 Oct; 90(4):746-52. PubMed ID: 27325183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and the Kidney: An Overview.
    Thurman JM
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):86-94. PubMed ID: 32553250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical approach to children with C3 glomerulopathy.
    Vivarelli M; van de Kar N; Labbadia R; Diomedi-Camassei F; Thurman JM
    Pediatr Nephrol; 2022 Mar; 37(3):521-535. PubMed ID: 34002292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement dysregulation in glomerulonephritis.
    Kaartinen K; Safa A; Kotha S; Ratti G; Meri S
    Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.
    Noris M; Remuzzi G
    Am J Kidney Dis; 2015 Aug; 66(2):359-75. PubMed ID: 26032627
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T; Nangaku M
    Kidney Int; 2013 Sep; 84(3):441-50. PubMed ID: 23615508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney, hypertension and complement activation. In search of new therapeutic targets.
    Rodríguez de Córdoba S; Espinosa Hernández M
    Nefrologia (Engl Ed); 2019; 39(2):111-114. PubMed ID: 30528890
    [No Abstract]   [Full Text] [Related]  

  • 17. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
    Koopman JJE; van Essen MF; Rennke HG; de Vries APJ; van Kooten C
    Front Immunol; 2020; 11():599974. PubMed ID: 33643288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement cascade and renal disease.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
    Kant S; Kronbichler A; Sharma P; Geetha D
    Am J Kidney Dis; 2022 Apr; 79(4):582-600. PubMed ID: 34508831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Goodship TH; Cook HT; Fakhouri F; Fervenza FC; Frémeaux-Bacchi V; Kavanagh D; Nester CM; Noris M; Pickering MC; Rodríguez de Córdoba S; Roumenina LT; Sethi S; Smith RJ;
    Kidney Int; 2017 Mar; 91(3):539-551. PubMed ID: 27989322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.